Related Experiment Video
Updated: Jun 1, 2026
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Summary
A phase 2 trial of doxorubicin, vinblastine, and gemcitabine for early-stage Hodgkin lymphoma showed inferior response rates. This highlights challenges in improving outcomes for this curable cancer.
Area of Science:
- Hematology
- Oncology
- Clinical Trials
Background:
- A phase 2 trial evaluated doxorubicin, vinblastine, and gemcitabine for early-stage, non-bulky Hodgkin lymphoma.
- The Cancer and Leukemia Group B (CALGB) conducted this study.
Discussion:
- The combination regimen demonstrated suboptimal efficacy compared to existing treatment standards.
- Complete response rates and progression-free survival were lower than anticipated.
Key Insights:
- Novel chemotherapy combinations may not always improve outcomes in highly curable cancers.
- Treatment intensification needs careful evaluation in early-stage Hodgkin lymphoma.
Outlook:
- Further research is needed to identify superior treatment strategies for early-stage Hodgkin lymphoma.
- Optimizing therapy for this patient population remains a critical clinical challenge.
Related Concept Videos
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:17Classification of Illness
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...